DE602006006177D1 - Biologisch absorbierbare füllstoffe bestehend aus phospholipidliposomen und hyaluronsäure und/oder derivaten davon - Google Patents

Biologisch absorbierbare füllstoffe bestehend aus phospholipidliposomen und hyaluronsäure und/oder derivaten davon

Info

Publication number
DE602006006177D1
DE602006006177D1 DE602006006177T DE602006006177T DE602006006177D1 DE 602006006177 D1 DE602006006177 D1 DE 602006006177D1 DE 602006006177 T DE602006006177 T DE 602006006177T DE 602006006177 T DE602006006177 T DE 602006006177T DE 602006006177 D1 DE602006006177 D1 DE 602006006177D1
Authority
DE
Germany
Prior art keywords
derivatives
hyaluronic acid
phospholipidliposomes
biologically absorbable
fillers containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006006177T
Other languages
English (en)
Inventor
Lanfranco Callegaro
Devis Galesso
Anna Taglienti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia Farmaceutici SpA
Original Assignee
Fidia Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici SpA filed Critical Fidia Farmaceutici SpA
Publication of DE602006006177D1 publication Critical patent/DE602006006177D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
DE602006006177T 2005-05-20 2006-04-21 Biologisch absorbierbare füllstoffe bestehend aus phospholipidliposomen und hyaluronsäure und/oder derivaten davon Active DE602006006177D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000146A ITPD20050146A1 (it) 2005-05-20 2005-05-20 Fillers riassorbibili costituiti da liposomi e acido ialuronico e o suoi derivati
PCT/EP2006/003898 WO2006122638A1 (en) 2005-05-20 2006-04-21 Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof

Publications (1)

Publication Number Publication Date
DE602006006177D1 true DE602006006177D1 (de) 2009-05-20

Family

ID=36734338

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006006177T Active DE602006006177D1 (de) 2005-05-20 2006-04-21 Biologisch absorbierbare füllstoffe bestehend aus phospholipidliposomen und hyaluronsäure und/oder derivaten davon

Country Status (12)

Country Link
US (1) US8263118B2 (de)
EP (1) EP1888013B1 (de)
JP (1) JP2008540588A (de)
AT (1) ATE427731T1 (de)
AU (1) AU2006246751B2 (de)
CA (1) CA2608811C (de)
DE (1) DE602006006177D1 (de)
ES (1) ES2325420T3 (de)
IT (1) ITPD20050146A1 (de)
PL (1) PL1888013T3 (de)
RU (1) RU2394552C2 (de)
WO (1) WO2006122638A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1742623A (zh) * 2005-07-13 2006-03-08 凌沛学 透明质酸磷脂复合物及其制备方法
US20070077292A1 (en) * 2005-10-03 2007-04-05 Pinsky Mark A Compositions and methods for improved skin care
JP2008133195A (ja) * 2006-11-27 2008-06-12 Konica Minolta Holdings Inc 水溶性薬剤内包リポソーム及びその製造方法
ITMI20072348A1 (it) 2007-12-17 2009-06-18 Medichem Srl Metodo per la rigenerazione cellulare di acido ialuronico e relativa composizione cosmetica
BE1018697A3 (fr) * 2009-03-16 2011-07-05 Auriga Internat Composition cosmetique a application topique comprenant de l'acide hyaluronique.
IT1395392B1 (it) * 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
CA2803034A1 (en) * 2010-06-17 2011-12-22 Jacob Klein Phosphatidylcholine lipid liposomes as boundary lubricants in aqueous media
RU2473352C2 (ru) 2011-04-21 2013-01-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" Состав, имитирующий внутрисуставную жидкость, и способ получения добавки к ней
CN102489193B (zh) * 2011-11-28 2014-06-18 上海景峰制药有限公司 一种玻璃酸钠配液过程的溶解方法
MX363462B (es) * 2012-10-11 2019-03-25 Ascendis Pharma As Diagnostico, prevencion y tratamiento de enfermedades de la articulacion.
US10413491B2 (en) 2014-04-02 2019-09-17 Merz Pharma Gmbh & Co. Kgaa In vivo accelerated degradation of polysaccharide-containing fillers
CN107073031B (zh) 2014-06-15 2021-08-24 耶达研究及发展有限公司 利用水溶性聚合物和脂质/脂质体的表面处理
CN106176632B (zh) * 2016-08-16 2019-09-03 海南合瑞制药股份有限公司 一种注射用甲泼尼龙琥珀酸钠组合物
ES2754476B2 (es) 2018-10-15 2020-09-14 Consejo Superior Investigacion Gel lipidico nanoestructurado, procedimiento de preparacion y uso

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713747D0 (en) * 1987-06-12 1987-07-15 Unilever Plc Skin treatment composition
DE4322158C2 (de) * 1993-07-03 1997-04-10 Rhone Poulenc Rorer Gmbh Phospholipidische Zusammensetzung sowie Verwendung einer derartigen Zusammensetzung
WO1996014083A1 (de) 1994-11-04 1996-05-17 Polymun Scientific Immunbiologische Forschung Gmbh Applikation von sod in liposomen
EP1231936A2 (de) 1999-10-27 2002-08-21 K-Quay Enterprises, LLC Verfahren und zusammensetzungen für behandlung von keratokonus mit proteaseinhibitoren
DE60012866T2 (de) * 1999-12-14 2005-09-08 Kibun Food Chemifa Co., Ltd. Propylenglykolhyaluronat und äusserlich anzuwendendes Hautpflegemittel, das dieses enthält
CA2451245A1 (en) * 2001-06-25 2003-01-03 Depuy International Limited Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints
DE60334581D1 (de) * 2002-06-20 2010-11-25 Yoshino Kogyosho Co Ltd Beutelförmiger blasgeformter Behälter
WO2004004671A1 (en) * 2002-07-02 2004-01-15 Procyte Corporation Compositions containing peptide copper complexes and soft tissue fillers
CN1255671C (zh) * 2002-08-02 2006-05-10 上海数康生物科技有限公司 多标志物生物芯片信号分析方法
US20080010413A1 (en) 2006-07-07 2008-01-10 Krishnan Kunjunny Kailas Method and apparatus for application-specific dynamic cache placement

Also Published As

Publication number Publication date
CA2608811C (en) 2013-11-26
EP1888013A1 (de) 2008-02-20
AU2006246751A1 (en) 2006-11-23
EP1888013B1 (de) 2009-04-08
ES2325420T3 (es) 2009-09-03
US8263118B2 (en) 2012-09-11
PL1888013T3 (pl) 2009-09-30
RU2394552C2 (ru) 2010-07-20
ITPD20050146A1 (it) 2006-11-21
WO2006122638A1 (en) 2006-11-23
US20120148667A1 (en) 2012-06-14
AU2006246751B2 (en) 2010-08-19
ATE427731T1 (de) 2009-04-15
JP2008540588A (ja) 2008-11-20
RU2007141864A (ru) 2009-06-27
CA2608811A1 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
DE602006006177D1 (de) Biologisch absorbierbare füllstoffe bestehend aus phospholipidliposomen und hyaluronsäure und/oder derivaten davon
CY1121134T1 (el) Συνθεσεις και μεθοδοι για την τροποποιηση της smn2 συγκολλησης
CY1118821T1 (el) Γελες με βαση υαλουρονικο οξυ οι οποιες περιλαμβανουν αναισθητικους παραγοντες
ATE504317T1 (de) Resorbierbares calciumphosphatbasierendes biopolymervernetztes knochenersatzmaterial
CY1117424T1 (el) Βενζοδιαζεπινικος αναστολεας bromodomain
BRPI0607009A2 (pt) stent endoureteral absorvìvel composto reforçada com fibra
WO2007064772A3 (en) Implantable microbial cellulose materials for various medical applications
BRPI0508403A (pt) produtos de pelìcula tendo propriedades de desintegração controlada
ATE554114T1 (de) Copolymer mit zwitterionischen einheiten und anderen einheiten, das copolymer umfassende zusammensetzung und verwendung
BRPI0510515A (pt) compostos de morfolina
WO2010093849A3 (en) Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
BRPI0609393B8 (pt) usos de um composto 11-desóxi-prostaglandina
DE602006018961D1 (de) KRISTALLINE FORMEN VON 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZOL, ZUBEREITUNGSVERFAHREN DAFÜR UND DESSEN VERWENDUNG ZUR ARZNEIMITTELHERSTELLUNG
BRPI0510336A (pt) monofilamento e método de utilização do mesmo e malha para hérnia e respectivo método de preparação
CY1111454T1 (el) Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων
TW200630374A (en) Thiazolyldihydroindazoles
ATE438404T1 (de) Verwendung von k-252a und kinasehemmern zur vorbeugung und behandlung von hmgb1-assoziierten pathologien
BRPI0606132A2 (pt) formas cristalinas de docetaxel e processos para seu preparo
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
WO2010002799A3 (en) Isolated extracellular matrix material including subserous fascia
BRPI0516568A (pt) biomateriais consistindo em ácido hialurÈnico sulfatado e gelana, bem como composição farmacêutica e uso dos mesmos
BRPI0718615B8 (pt) processo para produzir um material elástico a partir de tropoelastina e material elástico
CY1116832T1 (el) Συνθεσεις περιεχουσες ν-ακετυλγλυκοζαμινη για χρηση στη δερμοκοσμητολογια και στην αισθητικη ιατρικη
CY1115384T1 (el) Αντι-φλεγμονωδης συνθεση
ATE443722T1 (de) Peptide und peptidderivate, ihre herstellung sowie ihre verwendung zur herstellung einer therapeutisch und/oder prophylaktisch wirksamen pharmazeutischen zusammensetzung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition